Sun Pharma gets nod from South African regulator for generic semaglutide injection
AI Summary
Sun Pharmaceutical Industries has received approval from South Africa's regulatory body to manufacture and market a generic version of semaglutide injection, used for managing type 2 diabetes. This move could provide more affordable treatment options for patients in South Africa, addressing a significant healthcare need. Given semaglutide's growing recognition for both diabetes management and weight loss, this approval highlights the company's expanding global footprint in the pharmaceutical sector.
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.